HC Wainwright & Co. Reiterates Buy on MiMedx Group, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterated a Buy rating on MiMedx Group (NASDAQ:MDXG) with a maintained price target of $11.
May 01, 2024 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating on MiMedx Group with a price target of $11, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $11 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong confidence in MiMedx Group's future performance. This endorsement is likely to instill positive sentiment among investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100